3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Leukemia, Myeloid, Acute
3
Congenital Abnormalities
3
Carcinoma, Hepatocellular
3
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Stomach Neoplasms
1
Sarcoma
1
Prostatic Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma
1
Lymphedema
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Hematologic Neoplasms
1
Fibrosis
1
Esophageal Neoplasms
1
Deglutition Disorders
1
Cardiovascular Diseases
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Exercise
4
Cholecalciferol
4
Nutrition Assessment
3
Gonadotropin-Releasing Hormone
3
Blood Pressure
3
Atorvastatin
3
palbociclib
2
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
acalabrutinib
2
Vitamin E
2
Social Determinants of Health
2
Rosuvastatin Calcium
2
Metformin
2
Geritol
2
Fish Oils
2
Fatty Acids, Omega-3
2
Ethanol
2
Electrocardiography
2
Educational Status
2
Echocardiography
2
Diet, Mediterranean
2
Blood Specimen Collection
2
Aspirin
2
Antineoplastic Agents
2
Absorptiometry, Photon
2
zanubrutinib
1
xinmailong
1
ribociclib
1
phosphoribosylformylglycinamidine synthetase
1
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cardiovascular Diseases
×
Pravastatin
×
Clear all
NCT03127631
2025-01-31
RADICALPC
McMaster University
Phase NA
Recruiting
6,000 enrolled